Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
31 Julho 2024 - 9:37AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934
For the month of July 2024
Commission File Number: 001-34563
CONCORD MEDICAL SERVICES HOLDINGS LIMITED
Room A1-A5 26/F, East Zone, Hanwei Plaza
No. 7 Guanghua Road, Chaoyang District,
Beijing 100020
People’s Republic of China
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F.
Form 20-F x Form 40-F ¨
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ¨
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ¨
Concord Healthcare Announces Termination of Voting Proxy Arrangement
Concord
Healthcare Group Co., Ltd. (“Concord Healthcare”), a subsidiary of Concord Medical Services Holdings Limited (the “Company”)
(NYSE: CCM), which subsidiary is listed on the Main Board of The Stock Exchange of Hong Kong Limited (the “HKSE”) under the
stock code 2453.HK, announced the termination of voting proxy arrangement between Medstar (Shanghai) Financial Leasing Co., Ltd.
(“Shanghai Medstar”), a subsidiary of the Company, and five non-controlling shareholders of Concord Healthcare (collectively,
the “Proxy Granters”) on July 31, 2024. Each of the Proxy Granters had previously irrevocably delegated its voting
rights in the general meeting of shareholders of Concord Healthcare to Shanghai Medstar (collectively, the “Voting Proxy Arrangement”).
On July 31, 2024, Shanghai Medstar and the Proxy Granters terminated the Voting Proxy Arrangement upon negotiation in good faith
with immediate effect.
The Company previously announced the listing of Concord Healthcare’s
H shares on the HKSE on January 9, 2024. The information related to Concord Healthcare’s Transactions on the HKSE is accessible
through the HKSE’s website at www.hkexnews.hk.
SIGNATURE
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
CONCORD MEDICAL SERVICES HOLDINGS LIMITED |
|
|
|
|
By: |
/s/ Jianyu Yang |
|
Name: |
Jianyu Yang |
|
Title: |
Chairman and Chief Executive Officer |
Date: July 31, 2024
Concord Medical Services (NYSE:CCM)
Gráfico Histórico do Ativo
De Set 2024 até Out 2024
Concord Medical Services (NYSE:CCM)
Gráfico Histórico do Ativo
De Out 2023 até Out 2024